Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Appointment of Joint Broker

1 Aug 2018 07:00

RNS Number : 3910W
Craneware plc
01 August 2018
 

Craneware plc

("Craneware" or the "Company")

 

Appointment of Joint Broker

 

1 August 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce the appointment of Investec Bank plc as the Company's Joint Broker with immediate effect.

 

Peel Hunt remains the Company's Nominated Adviser and Joint Broker.

 

For further information, please contact:

 

Craneware plc

+44 (0)131 550 3100

 

Keith Neilson, CEO

 

Craig Preston, CFO

 

 

Peel Hunt (NOMAD and Joint Broker)

+44 (0)20 7418 8900

 

Dan Webster/ George Sellar

 

 

Investec Bank (Joint Broker)

+44 (0) 20 7597 5970

 

Patrick Robb/ Sebastian Lawrence/ Henry Reast

 

 

Alma (Financial PR)

+44 (0)208 004 4217

 

Caroline Forde/ Robyn Fisher/ Josh Royston

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 300 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APPRBMRTMBAJBAP

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.